Cabaletta Bio (CABA) Operating Expenses (2018 - 2025)

Cabaletta Bio has reported Operating Expenses for 8 years, with the latest figure at $42.6 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses rose 26.12% year-over-year to $42.6 million; the trailing twelve-month figure through Dec 2025 stood at $172.2 million (up 37.64% YoY), and the FY2025 full-year result was $172.2 million, up 37.64% from the prior year.
• Operating Expenses for Q4 2025 stood at $42.6 million, down from $46.6 million in the prior quarter.
• The five-year high for Operating Expenses was $46.6 million in Q3 2025, with the low at $9.7 million in Q1 2021.
• Average Operating Expenses over 5 years is $23.6 million, with a median of $17.8 million recorded in 2023.
• Year-over-year, Operating Expenses increased 1.86% in 2022 and surged 90.55% in 2024.
• Tracing CABA's Operating Expenses over 5 years: stood at $13.9 million in 2021, then gained by 17.34% to $16.3 million in 2022, then jumped by 41.98% to $23.1 million in 2023, then soared by 45.96% to $33.8 million in 2024, then climbed by 26.12% to $42.6 million in 2025.
• The last three Operating Expenses figures came in at $42.6 million (Q4 2025), $46.6 million (Q3 2025), and $45.9 million (Q2 2025), per Business Quant data.

Peer Comparison